Pituitary metastasis from renal cell carcinoma is rare and has never been reported for renal cell carcinoma primarily treated with sorafenib. Herein, we present a case of an advanced clear-ce ll renal cell carcinoma in which pituitary metastasis progressed but extracerebral metastases showed partial response to sorafenib treatment.
CITATION STYLE
Yang, L., Yu, S. Y., & Hu, G. Y. (2013). Pituitary menastasis from arenal cell carcinoma prosressed after sorafenib treatment. Chinese Journal of Cancer, 32(6), 353–356. https://doi.org/10.5732/cjc.012.10184
Mendeley helps you to discover research relevant for your work.